BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29963349)

  • 1. Variants in
    Zargar S; Aljafari AA; Wani TA
    3 Biotech; 2018 Jul; 8(7):289. PubMed ID: 29963349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis.
    Liu Y; Niu W; Wu Z; Su X; Chen Q; Lu L; Jin W
    PLoS One; 2012; 7(2):e31406. PubMed ID: 22363637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population.
    Han Y; Yang Y; Zhang X; Yan C; Xi S; Kang J
    Clin Chem Lab Med; 2007; 45(8):987-92. PubMed ID: 17579569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Association between the MEF2A Gene and Coronary Artery Disease in Iranian Families.
    Inanloo Rahatloo K; Davaran S; Elahi E
    Iran J Basic Med Sci; 2013 Aug; 16(8):950-4. PubMed ID: 24106602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAG repeat polymorphism of the MEF2A gene is not associated with the risk of coronary artery disease among Taiwanese.
    Hsu LA; Chang CJ; Teng MS; Semon Wu ; Hu CF; Chang WY; Ko YL
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):301-5. PubMed ID: 19153100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of MEF2A gene polymorphisms with coronary artery disease.
    Foroughmand AM; Shahbazi Z; Galehdari H; Purmahdi Borujeni M; Dinarvand P; Golabgirkhademi K
    Iran Red Crescent Med J; 2014 Aug; 16(8):e13533. PubMed ID: 25389475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEF2A gene and susceptibility to coronary artery disease in the Chinese people.
    Yuan H; Lü HW; Hu J; Chen SH; Yang GP; Huang ZJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):453-7. PubMed ID: 16951497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural changes in exon 11 of MEF2A are not related to sporadic coronary artery disease in Han Chinese population.
    Dai DP; Zhou XY; Xiao Y; Xu F; Sun FC; Ji FS; Zhang ZX; Hu JH; Guo J; Zheng JD; Dong JM; Zhu WG; Shen Y; Qian YJ; He Q; Cai JP
    Eur J Clin Invest; 2010 Aug; 40(8):669-77. PubMed ID: 20546016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction.
    González P; García-Castro M; Reguero JR; Batalla A; Ordóñez AG; Palop RL; Lozano I; Montes M; Alvarez V; Coto E
    J Med Genet; 2006 Feb; 43(2):167-9. PubMed ID: 15958500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 6-bp deletion in MEF2A linked to premature coronary artery disease in a large Chinese family.
    Xu DL; Tian HL; Cai WL; Zheng J; Gao M; Zhang MX; Zheng ZT; Lu QH
    Mol Med Rep; 2016 Jul; 14(1):649-54. PubMed ID: 27221044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Study of transcription factor MEF2A gene polymorphisms in patients with coronary artery disease.
    Muhammad Sulaiman K
    Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):80-86. PubMed ID: 38372109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease.
    Guella I; Rimoldi V; Asselta R; Ardissino D; Francolini M; Martinelli N; Girelli D; Peyvandi F; Tubaro M; Merlini PA; Mannucci PM; Duga S
    Circ Cardiovasc Genet; 2009 Apr; 2(2):165-72. PubMed ID: 20031581
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Jha CK; Mir R; Khullar N; Banu S; Chahal SMS
    J Cardiovasc Dev Dis; 2018 May; 5(2):. PubMed ID: 29843469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor MEF2A mutations in patients with coronary artery disease.
    Bhagavatula MR; Fan C; Shen GQ; Cassano J; Plow EF; Topol EJ; Wang Q
    Hum Mol Genet; 2004 Dec; 13(24):3181-8. PubMed ID: 15496429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the role of the Myocyte-specific Enhancer Factor-2A gene in coronary artery disease.
    Elhawari S; Al-Boudari O; Muiya P; Khalak H; Andres E; Al-Shahid M; Al-Dosari M; Meyer BF; Al-Mohanna F; Dzimiri N
    Atherosclerosis; 2010 Mar; 209(1):152-4. PubMed ID: 19782985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of MEF2A gene 3'UTR mutations with coronary artery disease.
    Huang XC; Wang W
    Genet Mol Res; 2015 Sep; 14(3):11073-8. PubMed ID: 26400337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEF2A gene mutations and susceptibility to coronary artery disease in the Chinese population.
    Li J; Chen HX; Yang JG; Li W; Du R; Tian L
    Genet Mol Res; 2014 Oct; 13(4):8396-402. PubMed ID: 25366733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family.
    Maiolino G; Colonna S; Zanchetta M; Pedon L; Seccia TM; Cesari M; Vigili de Kreutzenberg S; Avogaro A; Rossi GP
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):557-60. PubMed ID: 21450604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of MEF2A mutations in coronary artery disease.
    Weng L; Kavaslar N; Ustaszewska A; Doelle H; Schackwitz W; Hébert S; Cohen JC; McPherson R; Pennacchio LA
    J Clin Invest; 2005 Apr; 115(4):1016-20. PubMed ID: 15841183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between the MEF2A gene and myocardial infarction.
    Lieb W; Mayer B; König IR; Borwitzky I; Götz A; Kain S; Hengstenberg C; Linsel-Nitschke P; Fischer M; Döring A; Wichmann HE; Meitinger T; Kreutz R; Ziegler A; Schunkert H; Erdmann J
    Circulation; 2008 Jan; 117(2):185-91. PubMed ID: 18086930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.